Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015

Eur Respir J. 2017 Apr 12;49(4):1602309. doi: 10.1183/13993003.02309-2016. Print 2017 Apr.

Margareth Dalcolmo^{1

2}, Regina Gayoso^{1

2}, Giovanni Sotgiu^{3

2}, Lia D'Ambrosio^{4

5

2}, Jorge Luiz Rocha¹, Liamar Borga¹, Fatima Fandinho⁶, Jose Ueleres Braga⁷, Denise Arakaki Sanchez⁸, Fernanda Dockhorn⁸, Rosella Centis⁴, Giovanni Battista Migliori⁹

¹ Hélio Fraga Reference Center, Fiocruz/MoH, Rio de Janeiro, Brazil.
² These authors contributed equally to this work.
³ Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.
⁴ World Health Organization Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS Tradate, Tradate, Italy.
⁵ Public Health Consulting Group, Lugano, Switzerland.
⁶ National Mycobacteriology Laboratory, CRPHF, National TB Reference Center, Fiocruz/MoH, Rio de Janeiro, Brazil.
⁷ National Public Health School, Epidemiology Department, Fiocruz/MoH, Rio de Janeiro, Brazil.
⁸ National Tuberculosis Control Programme, SVS, Ministry of Health, Brazil.
⁹ World Health Organization Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS Tradate, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

No abstract available

Publication types